Navigation Links
Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
Date:4/6/2009

Clinical Force, a web based CTMS (Clinical Trial Management System), has announced that Gemin X Pharmaceuticals has selected and deployed Clinical Force to manage worldwide clinical trials. "We have deployed the Project Management, Regulatory/Ethics Management, CRF Tracking, Visit Reports, and Site Payments modules as well as the Offline Client. Future phases of our project will include integration to our EDC system(s), rollout of the new Clinical Supplies module" said Kevin Rechkemmer, Clinical Information Science Manager, Clinical Operations, Gemin X Pharmaceuticals.

Raleigh, NC (PRWEB) April 6, 2009 -- Clinical Force, the first SaaS, software as a service, CTMS, announces that Gemin X Pharmaceuticals has selected Clinical Force to manage worldwide clinical trials.

As an emerging biotech company working in oncology therapeutics with operations in Montreal Canada and Malvern Pennsylvania, Gemin X Pharmaceuticals selected Clinical Force based on its cost effective monthly subscription fees, adaptable infrastructure requiring no internal IT investment or support, and flexible user interface. In addition, Gemin X expects to improve study efficiencies by requiring their CROs to use Clinical Force on outsourced studies.

"After an extensive review process we felt Clinical Force's modular and cost effective solution met our needs. We have deployed the Project Management, Regulatory/Ethics Management, CRF Tracking, Visit Reports, and Site Payments modules as well as the Offline Client. Future phases of our project will include integration to our EDC system(s), rollout of th
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
2. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
3. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
4. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
5. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
6. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
7. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
8. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
9. VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
10. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
11. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) ... 28 with patients and health care advocates in the ... Disease Day®. Rare Disease Day is dedicated to ... to the special challenges faced by patients with rare ... is proud to stand alongside patients and caregivers representing ...
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015 /PRNewswire/ ... appointment of Kate Black as Privacy Officer ... international, federal, and state privacy laws as well as ... and regulatory team, she will be responsible for reviewing, ... for customers in the U.S. and abroad. She joined ...
(Date:2/26/2015)... Fla. , Feb. 26, 2015 DuPont ... growth priorities driven by key research advancements and product ... at today,s Bank of America Merrill Lynch 2015 Global ... the challenge of building grain supplies the last two ... continue at the pace of the last decade, when ...
(Date:2/26/2015)... BioEnterprise today announced that Northeast Ohio ... in growth funding during the past 13 years.  Funding ... – including the Ohio Third Frontier - and federal ... raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4
... Baltimore (UMB) BioPark today announced that Gliknik Inc., ... the BioInnovation,Center, located in UMB BioPark,s Building Two., ... autoimmune diseases,and cancer, the foundation of which resulted ... and Chairman of the Department of,Otorhinolarynogology, University of ...
... PALM BEACH, Fla., Jan. 9 Workforce Alliance, ... in Palm Beach,County, is closing a grant program ... and prepare for employment in the life sciences ... The Workforce Alliance,s expiring Biotechnology Training Grant was,funded ...
... 9 PAREXEL International,Corporation (Nasdaq: PRXL ), ... Eduard E. Holdener, M.D., formerly Head,of Global Pharmaceutical ... to its Board of Directors., Dr. Holdener ... of NovImmune. The biotechnology Company develops new therapeutic,agents ...
Cached Biology Technology:University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two 2Workforce Alliance Concludes Three-Year Biotech Training Program 2PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors 2PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors 3PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors 4
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... , January 28, 2015 New ... Size And Segment Forecasts To 2020 has Been Added ... camera market is expected to reach USD 5.10 billion ... View Research, Inc. IR cameras help identify the site ... expected to witness surging demand in medical imaging applications. ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... novel cell therapy using retinal pigment epithelial (RPE) ... in the brain can improve the symptoms of ... Rush University Medical Center neurosurgeon Dr. Roy ... Atlanta found the therapy Spheramine was well-tolerated and ...
... Norwegian Institute of Public Health has published an overview ... in Norway from 2001-2007. The sales are shown in ... for sea lice and fungi. The figures are based ... mills to breeders. After an increase in ...
... important signaling molecule in plants - as in mammals ... as a model plant, researchers have found that nitric ... plants. In collaborative work with the research group ... student at the Botany Department, University of Delhi, India, ...
Cached Biology News:Cell-based therapy shows promise in patients with Parkinson's disease 2Cell-based therapy shows promise in patients with Parkinson's disease 3Nitric oxide regulates plants as well as people 2
Anti-Protein Kinase-A (PKA) Regulatory subunit IIB; rabbit host...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Mouse monoclonal antibody to RNase L...
Compact, portable device, seals 96 and 384 well plates with preset temperature optimised for Eppendorf heat sealing foils and films. Suitable for plates of different heights. AC input: 50/60 Hz230 V...
Biology Products: